Abstracts are welcomed on all aspects of stroke research at the UK Stroke Forum (UKSF) Conference on 28-30 November 2017. Lead authors can submit a maximum of two abstracts.
The deadline for abstract submissions is 5pm on 9 June 2017.
No submissions will be accepted after this time. Applicants will be notified of the outcome via email by 7 August 2017.
There are two abstract varieties: research or service development with different types.
How to submit an abstract
You must use the UKSF abstract online submission system and select the relevant submission type when prompted.
You will be prompted to provide the following information:
List of author(s) and institution(s)
Please write the surname first followed by the initial(s) for each author. The lead/presenting author needs to be listed first. Institution details should be provided for each author including department, institution and country.
Superscript numbers must be used for reference to the institution but please note that in the system, as you type, they will show as non-superscript numbers. If all authors are from one institution this only needs to be written once.
Brown SE1, Bloggs A1, Smith TH2
1Department of Stroke Medicine, London Hospital, UK, 2Department of Rehabilitation, University of Zurich, Switzerland
List the organisation(s) that have funded the work.
Insert the abstract title, which should be descriptive.
Please note abstracts must not exceed 250 words overall. Figures, tables or graphs aren't permitted.
Ensure you structure content in the boxes in the system marked with the following headings: Introduction, Method, Results and Conclusion.
Avoid complex mathematical formulae. For plus/minus symbols, type + or - instead of ±. Avoid Greek letters and symbols: for example use 'IFN-g' or 'IFN-gamma'.
Please select from the dropdown list which type of abstract you're submitting (type 1, 2, 3 or 4 - see above for what each type represents).
Please select either randomised clinical trial or other study design.
Authors submitting abstracts for clinical trials or other studies will also need to indicate which area is most appropriate from the drop-down list in the online system.
In the online system, you'll be asked to select one of the following:
UK Stroke Forum member
Please indicate which UKSF organisation you’re a member of or are associated with. This will be used for data analysis purposes only, and will assist with identifying appropriate peer reviewers for the abstract and eligibility for prizes.
Abstracts selected for oral or poster presentation will be published in a supplement to the 'International Journal of Stroke' (except type 3 – ongoing clinical trials or other studies). This will be distributed to delegates attending the UKSF Conference and will also be available online.
Authors who are successful at securing an oral presentation of their abstract will be allocated up to 15 minutes to present at the conference (including questions and subject to programme session timings). Authors will receive confirmation of their presentation date, time and allocated session by email, along with instructions on how their PowerPoint presentations should be received.
Poster presentations should be in landscape format, (A0 size landscape posters, 1189mm x 841mm preferably). The conference programme will include dedicated times for guided poster tours, which will take place on the main conference days.
Type 3 – ongoing clinical trials or other studies will qualify for poster presentation only, will not be included in the poster tour and will not be featured in the 'International Journal of Stroke', but will feature in the programme booklet.
Details of allocated poster tours, sessions and further instructions for poster presenters will be emailed following the abstract selection process.
All lead authors of abstracts selected for oral or poster presentation must register as paying delegates to attend the UKSF Conference.
Any other authors attending will also need to register as paying delegates. If another author is attending in place of the lead author we will require written confirmation sent to UKSFabstracts@stroke.org.uk
You should consider your availability, likely outcomes and ability to gain funding if you're chosen as an abstract presenter. Please note that the UKSF cannot fund any registration costs for those chosen to attend as oral or poster abstract presenters.
Prizes for 2017
The UKSF recognises excellence by awarding abstract prizes to the lead author at the conference. These prizes are:
Important things to note about submitting abstracts
- In order to determine your eligibility for the above prizes, please ensure you select which member organisation you represent eg BASP, NSNF etc.
- All abstracts will be reviewed by a multi-disciplinary team overseen by the UKSF Conference Scientific Programme Committee to ensure consistency and objectivity.
- Authors will be contacted by 7 August 2017. Only the stated lead author (presenting author) will receive emails about the acceptance and placement of the abstract and it is their responsibility to inform any co-authors.
- Abstracts selected for presentation at the event will be published in a special edition of the 'International Journal of Stroke' apart from type 3 – ongoing clinical trials or other studies, which will qualify for poster presentation only and will not be included in the poster tour or feature in the 'International Journal of Stroke', but will feature in the programme booklet.
- If abstracts are accepted, authors/co-authors attending will be required to register in full to attend the conference.
All correspondence from the UKSF regarding the abstract will be sent to the lead author’s email address only. To contact us please email UKSFabstracts@stroke.org.uk